By Hendra Lukman 
In a significant breakthrough with profound implications for global health and sustainable food production, scientists have developed a method to cultivate Spirulina, a nutrient-dense algae, to produce biologically active vitamin B12 at levels comparable to those found in beef. This pioneering research, published in the esteemed journal Discover Food, addresses a long-standing nutritional challenge associated with Spirulina, a widely promoted dietary supplement and food source, by overcoming its previous limitation of containing primarily inactive forms of the essential vitamin.
The collaborative effort, spearheaded by Dr. Asaf Tzachor, Founder and Academic Director of the Aviram Sustainability and Climate Program at Reichman University, involved an international team of researchers from Iceland, Denmark, and Austria. Their innovative approach utilizes advanced biotechnology and meticulously controlled photonic conditions to yield carbon-neutral, nutrient-rich Spirulina biomass that is exceptionally high in active vitamin B12. This marks the first documented instance of biologically active vitamin B12 being successfully cultivated in Spirulina, opening new avenues for dietary fortification and the development of novel food sources.
The Pervasive Challenge of Vitamin B12 Deficiency
Vitamin B12, also known as cobalamin, is an indispensable micronutrient crucial for a multitude of vital bodily functions. It plays a pivotal role in the synthesis of DNA, the formation of red blood cells, and the maintenance of a healthy nervous system. Despite its critical importance, a staggering global health issue persists: over a billion people worldwide are estimated to suffer from insufficient levels of this essential vitamin. This widespread deficiency can lead to a range of serious health complications, including megaloblastic anemia, neurological damage, and impaired cognitive function, particularly in vulnerable populations such as the elderly, pregnant women, and individuals adhering to strict vegetarian or vegan diets.
Historically, animal-based products – including meat, poultry, fish, eggs, and dairy – have been the primary dietary sources of bioavailable vitamin B12. The recommended daily intake for adults, as cited by the researchers, is 2.4 micrograms (µg). However, meeting this global demand through conventional animal agriculture presents a significant environmental burden. The extensive land use, water consumption, greenhouse gas emissions, and resource intensity associated with raising livestock contribute substantially to climate change and ecological degradation. This growing awareness of the environmental costs has spurred an urgent search for more sustainable and ethically produced alternatives.
Spirulina (Arthrospira platensis), a blue-green algae, has long been heralded as a promising sustainable food source. Its remarkable nutritional profile, boasting high concentrations of protein, vitamins, minerals, and antioxidants, combined with its relatively low environmental footprint for cultivation, has positioned it as a potential solution for food security and nutritional enhancement. Yet, its widespread adoption as a reliable source of vitamin B12 has been hampered by a critical flaw: the form of B12 it typically contains.
Decoding the Pseudo-Vitamin B12 Conundrum
The majority of vitamin B12 found in conventionally grown Spirulina exists in the form of "pseudo-vitamin B12." While structurally similar to the active form of vitamin B12 that humans require, these analogues are not readily absorbed or utilized by the human body. This lack of bioavailability renders traditional Spirulina ineffective as a primary source for preventing or treating vitamin B12 deficiency, thereby limiting its potential to replace animal-derived B12 in diets. Researchers have long sought to unlock Spirulina’s potential by finding ways to enhance its production of the genuinely active form of the vitamin.
Photonic Management: The Key to Active Vitamin B12 Production
The breakthrough achieved by Dr. Tzachor and his international collaborators emerged from an exploratory study of a specialized biotechnology platform developed by VAXA Technologies in Iceland. The research team, comprising scientists from Reichman University, the University of Natural Resources and Life Sciences, Vienna, Ruppin Academic Center, the Danish Technological Institute, and MATIS, Iceland, meticulously examined the engineering design of the VAXA system, its energy inputs, and the resulting nutritional composition of the cultivated Spirulina biomass.
At the heart of VAXA’s innovative technology lies "photonic management," a sophisticated manipulation of light conditions during the algae’s growth cycle. By precisely altering the spectrum, intensity, and duration of light exposure, the researchers were able to significantly influence the metabolic pathways within the Spirulina cells. This controlled environment effectively stimulated the organism to produce higher quantities of biologically active vitamin B12, rather than its inactive analogues.
The findings revealed that the Spirulina cultivated under these advanced photonic conditions not only contained substantial amounts of active vitamin B12 but also exhibited a broader spectrum of beneficial bioactive compounds. These included potent antioxidants, anti-inflammatory agents, and immune-boosting substances, further enhancing the overall health benefits of the algae.
Crucially, the carbon-neutral biomass produced by this method demonstrated an impressive concentration of 1.64 µg of active vitamin B12 per 100 grams. To put this into perspective, this figure is directly comparable to, and in some cases exceeds, the active B12 content found in beef, which typically ranges from 0.7 to 1.5 µg per 100 grams.
Dr. Asaf Tzachor articulated the significance of these findings, stating, "The findings demonstrate that photosynthetically controlled Spirulina can produce desirable levels of active vitamin B12, offering a sustainable alternative to traditional animal-source foods." This statement underscores the transformative potential of the research in providing a viable, environmentally conscious solution to a critical global nutritional gap.
Scaling Up: The Vision for Global Vitamin B12 Sufficiency
Beyond the laboratory-scale success, the researchers delved into the scalability of this technology, exploring its potential to meet global vitamin B12 demands. Their projections paint a compelling picture of what could be achieved if the system were expanded significantly.
In one hypothetical scenario, the researchers calculated that reallocating a portion of the electricity currently consumed by heavy industry in Iceland could support the annual production of an estimated 277,950 tonnes of Spirulina biomass. This substantial output, they estimate, would yield approximately 4,555 grams of active vitamin B12 annually.
Based on their calculations, this projected quantity of active vitamin B12 could fulfill the recommended dietary allowance (RDA) for over 13.8 million children aged 1-3 years. Furthermore, more ambitious production scenarios, envisioning even greater scale-up, could potentially generate enough vitamin B12 to meet the RDA for more than 26.5 million children aged 1-3 and upwards of 50 million infants aged 0-6 months. While these figures represent projections based on potential scale-up, they powerfully illustrate the immense nutritional capacity of this biotechnology.
A Sustainable Paradigm Shift in Nutrient Sourcing
The successful expansion of this photosynthetically controlled Spirulina cultivation method holds the promise of providing another critical pathway for addressing widespread vitamin B12 deficiency. Moreover, it offers a tangible opportunity to reduce our reliance on resource-intensive meat and dairy production, thereby contributing to a more sustainable global food system.
This groundbreaking work also highlights the transformative power of biotechnology in enhancing the nutritional value of microorganisms and other rapidly growing food sources. Instead of merely cultivating existing strains of Spirulina, researchers are actively engineering its growth conditions to optimize the production of specific, human-beneficial compounds. This represents a paradigm shift from passive cultivation to active nutritional bio-engineering.
The findings from this research mark a significant stride towards developing more sustainable and accessible sources of essential nutrients. However, the researchers acknowledge that further research and large-scale production trials are imperative to fully assess the technology’s integration into real-world food systems and to confirm its economic viability and widespread applicability.
The Aviram Program: Fostering Sustainability Solutions
The Aviram Sustainability and Climate Program at Reichman University, which Dr. Asaf Tzachor leads, was established in direct response to the escalating environmental and public health challenges facing the planet. This program is dedicated to cultivating a new generation of interdisciplinary leaders equipped to develop innovative strategies for tackling complex issues such as resource scarcity, the accelerating impacts of climate change, extreme weather events, and the critical crises in food, water, and energy security. The research into vitamin B12-rich Spirulina is a prime example of the program’s commitment to translating scientific inquiry into practical, sustainable solutions for a healthier planet and population. The international collaboration underscores the global nature of these challenges and the necessity of cross-border scientific cooperation to address them effectively. As discussions around food security and climate resilience intensify, innovations like this offer a beacon of hope for a more sustainable future.
